ACT001 inhibits the proliferation of non-small cell lung cancer cells by upregulating NKTR expression.
Min ZhaoTingting QinDingzhi HuangPublished in: Thoracic cancer (2022)
Our results suggested NKTR may be the target of ACT001 in NSCLC. ACT001 holds promise as a novel method for the treatment of NSCLC.